| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | 1 | — | — | — | — | — | — | — | — | — | — |
| Sell | — | 1 | — | 11 | 6 | 11 | — | — | 1 | — | — | 1 |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 3.73 |
—
—
—
|
| 2025 | 3.30 |
—
—
—
—
|
| 2024 | 3.00 |
—
—
—
—
|
| 2023 | 2.80 |
—
—
—
—
|
| 2022 | 2.60 |
—
—
—
—
|
| 2021 | 2.30 |
—
—
—
—
|
| 2020 | 2.18 |
—
—
—
—
|
| 2019 | 2.05 |
—
—
—
—
|
| 2018 | 1.86 |
—
—
—
—
|
| 2017 | 1.70 |
—
—
—
—
|
| 2016 | 1.64 |
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 458.00 | 414.00 | 201.00 | 557.00 |
| Receivables | 2,870.00 | 3,687.00 | 4,055.00 | 4,206.00 |
| Inventory | 173.00 | 206.00 | 225.00 | 232.00 |
| Other | 303.00 | 467.00 | 429.00 | 402.00 |
| 3,804.00 | 4,774.00 | 4,910.00 | 5,397.00 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 1,709.00 | 2,046.00 | 1,867.00 | 1,992.00 |
| ST’ Debt | 334.00 | 1,359.00 | 711.00 | 1,075.00 |
| Other | — | — | — | — |
| 4,226.00 | 6,258.00 | 5,524.00 | 5,948.00 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 6,227.00 | 6,684.00 | — | — |
—
|
| ’25 | 6,018.00 | 6,430.00 | 6,443.00 | 6,313.00 |
25,204.00
|
| ’24 | 5,159.00 | 5,402.00 | 5,609.00 | 5,893.00 |
22,063.00
|
| ’23 | 4,892.00 | 5,119.00 | 5,198.00 | 5,217.00 |
20,426.00
|
| ’22 | 4,661.00 | 5,027.00 | 5,075.00 | 4,935.00 |
19,698.00
|
| ’21 | 4,112.00 | 4,476.00 | 4,665.00 | 4,678.00 |
17,931.00
|
| ’20 | 3,729.00 | 3,561.00 | 3,861.00 | 4,067.00 |
15,218.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 1,501.00 | 1,726.00 | — | — |
—
|
| ’25 | 1,208.00 | 1,545.00 | 1,592.00 | 1,698.00 |
6,043.00
|
| ’24 | 1,367.00 | 1,154.00 | 1,358.00 | 1,511.00 |
5,390.00
|
| ’23 | 1,044.00 | 1,030.00 | 1,263.00 | 1,382.00 |
4,719.00
|
| ’22 | 1,258.00 | 1,047.00 | 1,182.00 | 1,049.00 |
4,536.00
|
| ’21 | 1,120.00 | 1,043.00 | 1,184.00 | 991.00 |
4,338.00
|
| ’20 | 765.00 | 856.00 | 1,029.00 | 753.00 |
3,403.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 851.00 | 1,096.00 | — | — |
—
|
| ’25 | 377.00 | 813.00 | 816.00 | 810.00 |
2,816.00
|
| ’24 | 699.00 | 487.00 | 577.00 | 396.00 |
2,159.00
|
| ’23 | 384.00 | 510.00 | 590.00 | 340.00 |
1,824.00
|
| ’22 | 840.00 | 497.00 | 425.00 | 187.00 |
1,949.00
|
| ’21 | 850.00 | 647.00 | 720.00 | 217.00 |
2,434.00
|
| ’20 | 306.00 | 420.00 | 686.00 | 359.00 |
1,771.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 1.79 | 1.95 | — | — |
—
|
| ’25 | 1.58 | 1.80 | 1.49 | 1.83 |
6.70
|
| ’24 | 1.75 | 1.69 | 1.88 | 1.48 |
6.81
|
| ’23 | 1.30 | 1.51 | 1.63 | 1.22 |
5.66
|
| ’22 | 1.23 | 1.41 | 1.54 | 1.21 |
5.39
|
| ’21 | 0.99 | 0.83 | 1.28 | 1.20 |
4.29
|
| ’20 | 0.85 | 0.72 | 0.92 | 1.03 |
3.52
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 138.58 | 148.31 | 176.68 | 194.11 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 175.98 | 179.80 | 230.39 | 242.58 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 49,500 | 48,000 | 61,700 | 60,500 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.40 | 0.43 | 0.36 | 0.42 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 19,698.00 | 20,426.00 | 22,063.00 | 25,204.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 37.59% | 38.28% | 39.34% | 40.44% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,918.00 | 3,021.00 | 3,458.00 | 3,426.00 | ‡‡‡‡‡ | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 14.81% | 14.79% | 15.67% | 13.59% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,240.00 | 2,276.00 | 2,745.00 | 2,709.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,150.00 | 2,201.00 | 2,400.00 | 3,005.00 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 47.72 | 50.45 | 54.95 | 62.59 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 5.42 | 5.69 | 6.84 | 6.72 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 10.99 | 11.65 | 13.42 | 15.01 | ‡‡‡‡ | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (6.27) | (7.15) | (8.05) | (8.01) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.72 | 4.50 | 5.38 | 6.99 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 16.63 | 17.03 | 20.56 | 24.81 | ‡‡‡‡ | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 412.80 | 404.90 | 401.50 | 402.70 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 28.92 | 31.51 | 29.50 | 32.69 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.29 | 3.56 | 3.67 | 3.51 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9.44 | 10.55 | 9.82 | 8.86 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.03 | 4.33 | 4.74 | 4.41 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 40.77 | 48.52 | 48.40 | 39.48 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4,536.00 | 4,719.00 | 5,390.00 | 6,043.00 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (2,587.00) | (2,895.00) | (3,231.00) | (3,227.00) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,949.00 | 1,824.00 | 2,159.00 | 2,816.00 | ‡‡‡‡‡ | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (843.00) | (422.00) | (1,484.00) | (614.00) | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 14,984.00 | 16,229.00 | 23,900.00 | 22,907.00 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 14,633.00 | 15,771.00 | 23,486.00 | 22,706.00 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6,864.00 | 6,896.00 | 8,254.00 | 9,991.00 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.40% | 7.18% | 7.10% | 5.99% | ‡‡‡‡‡ | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9.78% | 9.86% | 8.00% | 8.23% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 31.99% | 33.49% | 36.25% | 29.68% | ‡‡‡‡‡ | — | — |
ROE
|
Waste Management, Inc. (WM) exemplifies resilience in the waste services sector, leveraging operational efficiencies, strategic acquisitions like the $4.9 billion Advanced Disposal deal, and innovations in renewable natural gas (RNG) and advanced recycling to drive robust growth amid urbanization and circular economy trends. Revenue has compounded at 7% annually from $13.6 billion in 2016 to $22.1 billion in 2024, with projections accelerating to $25.2 billion in 2025 (14% YoY) fueled by pricing power, municipal contracts, and green subsidies. Margins have expanded steadily—gross to 40.4% and EBT margins stabilizing at 15-16%—propelling EPS from $3.54 to a forecasted $10.69 by 2028, while ROE peaks at 36.3%, far outpacing peers.
Free cash flow per share has doubled to $6.99 by 2025, supporting dividends, buybacks, and capex for RNG facilities and fleet electrification, despite a debt spike to $23.9 billion likely tied to growth investments—net debt-to-equity remains manageable at 2.3x. Stock performance tightly correlates with these fundamentals: highs have risen 238% since 2016 alongside revenue beats, with EV/FCF compressing to attractive levels.
Trading at forward P/E of 29-33x (dipping to 22x by 2028), WM offers defensive stability with disruptive upside from RNG and AI optimizations potentially adding billions in high-margin revenue. Analyst targets imply 10-22% appreciation, insider activity signals routine confidence, and historical patterns point to 20%+ annualized returns for patient investors—explore the full analysis for deeper correlations and risk nuances.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.